Literature DB >> 22392934

The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.

Reza Bagheri1, Mohammad Taghi RajabiMashhadi, Kiyarash Ghazvini, Amir Asnaashari, Ali Zahediyan, Mehdi Abasi Sahebi.   

Abstract

Respiratory complication is one of the important postoperative complications of oesophageal cancer. The aim of this study was to evaluate whether neoadjuvant chemotherapy before surgery is effective for postoperative respiratory complications. In this study, patients with oesophageal cancer were divided into two group: one with neoadjuvant therapy and the other without neoadjuvant therapy. Before surgery, they all underwent bronchoscopy and bronchoalveolar lavage. We evaluated respiratory complications and the effects of preoperative neoadjuvant therapy. Forty patients (M/F = 23/17 and mean age 61 years) were enrolled in this study. Twenty-two cases had cancer in the middle part and 18 in the lower part of the oesophagus. Significant correlation was observed between the number of positive micro-organism and difficulty in weaning and receiving neoadjuvant therapy. But no significant correlation was found between neoadjuvant therapy and respiratory complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392934      PMCID: PMC3352705          DOI: 10.1093/icvts/ivs009

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  15 in total

1.  Preoperative chemoradiotherapy for esophageal cancer.

Authors:  D Kelsen
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

2.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

Review 3.  Treatment of localized esophageal cancer.

Authors:  Baruch Brenner; David H Ilson; Bruce D Minsky
Journal:  Semin Oncol       Date:  2004-08       Impact factor: 4.929

Review 4.  Induction therapy does not increase surgical morbidity after esophagectomy for cancer.

Authors:  Frank C-F Lin; Amy E Durkin; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

5.  Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.

Authors:  Alberto Ruol; Giuseppe Portale; Carlo Castoro; Stefano Merigliano; Matteo Cagol; Francesco Cavallin; Vanna Chiarion Sileni; Luigi Corti; Sabrina Rampado; Mario Costantini; Ermanno Ancona
Journal:  Ann Surg Oncol       Date:  2007-08-23       Impact factor: 5.344

6.  Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world.

Authors:  J R Siewert; H J Stein; M Feith; B L Bruecher; H Bartels; U Fink
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

7.  Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy.

Authors:  R C Karl; R Schreiber; D Boulware; S Baker; D Coppola
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

8.  Pulmonary complications after esophagectomy.

Authors:  Christopher E Avendano; Patrick A Flume; Gerard A Silvestri; Lydia B King; Carolyn E Reed
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

9.  Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction.

Authors:  O Hagry; W Coosemans; P De Leyn; P Nafteux; D Van Raemdonck; E Van Cutsem; K Hausterman; T Lerut
Journal:  Eur J Cardiothorac Surg       Date:  2003-08       Impact factor: 4.191

10.  Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy.

Authors:  John R Doty; Jorge D Salazar; Arlene A Forastiere; Elisabeth I Heath; Lawrence Kleinberg; Richard F Heitmiller
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

View more
  5 in total

1.  Postoperative complications do not affect long-term outcome in esophageal cancer patients.

Authors:  Kirsten Lindner; Mathias Fritz; Christina Haane; Norbert Senninger; Daniel Palmes; Richard Hummel
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 2.  Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients.

Authors:  Zhentao Yu; Shanqing Li; Deruo Liu; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Lei Gong; Hongdian Zhang; John B Downs; Nestor Villamizar; Shugeng Gao; Jie He
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

3.  Analyzing the impact of neoadjuvant radiation dose on pathologic response and survival outcomes in esophageal and gastroesophageal cancers.

Authors:  Richard Li; Ashwin Shinde; Scott Glaser; Joseph Chao; Jae Kim; Sana D Karam; Karyn Goodman; Yi-Jen Chen; Arya Amini
Journal:  J Gastrointest Oncol       Date:  2019-08

4.  The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery.

Authors:  Mohammadtaghi Rajabi Mashhadi; Reza Bagheri; Abbas Abdollahi; Mohammad Javad Ghamari; Soudabeh Shahidsales; Maryam Salehi; Reza Shahkaram; Mohamad Reza Majidi; Shima Sheibani
Journal:  Iran J Otorhinolaryngol       Date:  2015-07

5.  Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.

Authors:  Nina Nederlof; Annelijn E Slaman; Pieter van Hagen; Ate van der Gaast; Ksenija Slankamenac; Suzanne S Gisbertz; Jan J B van Lanschot; Bas P L Wijnhoven; Mark I van Berge Henegouwen
Journal:  Ann Surg Oncol       Date:  2016-06-14       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.